ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Gang Yang
Matched on OpenAlex author ID A5024590000. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- Artificial intelligence: Catalyzing a new era in pancreatic cancer cure. Co-author DOI 10.1016/j.canlet.2026.218558↗
- Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer. Co-author DOI 10.2147/cmar.s465098↗
- Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. Co-author DOI 10.1093/bjs/znac375↗
- Low hENT1 expression indicates poor prognosis in gemcitabine-treated pancreatic cancer patients Co-author DOI 10.21203/rs.2.17850/v1↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lei You · 3 shared papers, 2019–2026 · strength 0.54
- Paper Artificial intelligence: Catalyzing a new era in pancreatic cancer cure. DOI 10.1016/j.canlet.2026.218558↗
- Paper Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Tr… DOI 10.2147/cmar.s465098↗
- Paper Low hENT1 expression indicates poor prognosis in gemcitabine-treated pancreatic cancer patients DOI 10.21203/rs.2.17850/v1↗
- Yueze Liu · 3 shared papers, 2019–2024 · strength 0.46
- Paper Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Tr… DOI 10.2147/cmar.s465098↗
- Paper Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. DOI 10.1093/bjs/znac375↗
- Paper Low hENT1 expression indicates poor prognosis in gemcitabine-treated pancreatic cancer patients DOI 10.21203/rs.2.17850/v1↗
- Fangyu Zhao · 3 shared papers, 2019–2024 · strength 0.46
- Paper Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Tr… DOI 10.2147/cmar.s465098↗
- Paper Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. DOI 10.1093/bjs/znac375↗
- Paper Low hENT1 expression indicates poor prognosis in gemcitabine-treated pancreatic cancer patients DOI 10.21203/rs.2.17850/v1↗
- Taiping Zhang · 3 shared papers, 2019–2024 · strength 0.46
- Paper Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Tr… DOI 10.2147/cmar.s465098↗
- Paper Using a microRNA panel of circulating exosomes for diagnosis of pancreatic cancer: multicentre case-control study. DOI 10.1093/bjs/znac375↗
- Paper Low hENT1 expression indicates poor prognosis in gemcitabine-treated pancreatic cancer patients DOI 10.21203/rs.2.17850/v1↗
- Yupei Zhao · 2 shared papers, 2019–2026 · strength 0.33
- Jianchun Xiao · 2 shared papers, 2019–2024 · strength 0.30
- Wenhao Luo · 2 shared papers, 2019–2024 · strength 0.30
- Jiangdong Qiu · 2 shared papers, 2019–2023 · strength 0.25
- Jun Wang · 1 shared paper, 2026 · strength 0.24
- Jiangdong Qiu · 1 shared paper, 2024 · strength 0.21
- Guangbing Xiong · 1 shared paper, 2023 · strength 0.16
- Lei Wang · 1 shared paper, 2023 · strength 0.16
- Jinxin Tao · 1 shared paper, 2023 · strength 0.16
- Zhe Cao · 1 shared paper, 2023 · strength 0.16
- Guangyu Chen · 1 shared paper, 2023 · strength 0.16
- Renyi Qin · 1 shared paper, 2023 · strength 0.16
- Yi‐Cheng Wang · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.